Copernicus Therapeutics Inc.

Nucleic Acid Nanoparticles for Treating Human Diseases

CopernicusLogo1Cutout3.jpgTubes.jpg4413SM2.jpg

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

 


Chairman, Joseph Ashley
President & CEO, Robert C. Moen, M.D., Ph.D.
Senior VP Science & Medical Affairs, Mark J. Cooper, M.D.
Director, Allen H. Ford
Director, Glenn E. Corlett, Esq.

 


Copernicus' Laboratory & Administrative Staff

 


Linas Padegimas, Ph.D., Director of Molecular Biology
Özge Sesenoglu-Laird, Ph.D., Senior Scientist, Process Development
Freyda Sanders, CPA, Controller
Jan Candelaria, Manager, Administration

 


Copernicus' Scientific Founders include experts in gene therapy, molecular biology, biochemistry, pulmonology, and cancer.

 


Mark J. Cooper, M.D., CWRU and Copernicus Therapeutics, Inc.
Pamela Davis, M.D., Ph.D., Case Western Reserve University
Thomas Ferkol, M.D., Washington University at St. Louis
Richard Hanson*, Ph.D., Case Western Reserve University
Jose Perales, D.V.M., Ph.D., Universitat De Barcelona


* Dr. Richard Hanson passed away in February 2014.

MEET OUR PEOPLE

dsgn_764_but0_on.jpg